Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Li‐Zhi Liu
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy: A Meta-Analysis
Cancer Management and Research
Oncology
Less Is More: Role of Additional Chemotherapy to Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer Management
Radiation Oncology Journal
Oncology
Radiology
Nuclear Medicine
Imaging
Four-Year Outcome After Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase III, Multicentre, Randomised Controlled Trial
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Cytomembranic PD-L1 Expression in Locoregionally Advanced Nasopharyngeal Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Optimal Sequencing of Chemotherapy With Chemoradiotherapy Based on TNM Stage Classification and EBV DNA in Locoregionally Advanced Nasopharyngeal Carcinoma
Cancer Communications
Cancer Research
Oncology
A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study
Oncology Reports
Medicine
Cancer Research
Oncology
Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Chemoradiotherapy
PLoS ONE
Multidisciplinary
Anti-Egfr Targeted Therapy Delivered Before Versus During Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Big-Data, Intelligence Platform-Based Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Sorafenib With or Without Concurrent Transarterial Chemoembolization in Patients With Advanced Hepatocellular Carcinoma: A Phase III STAH Trial
Journal of Hepatology
Hepatology
